⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11133291 | 0.78 | — | — | |
| SCHEMBL20207315 | 0.76 | — | — | |
| SCHEMBL4884414 | 0.74 | — | — | |
| SCHEMBL23804911 | 0.72 | F2 (0.34) | — | |
| SCHEMBL27492522 | 0.71 | — | — | |
| SCHEMBL27744881 | 0.70 | CA2 (0.34) | — | |
| SCHEMBL23804917 | 0.70 | F2 (0.33) | — | |
| SCHEMBL5212940 | 0.69 | — | — | |
| SCHEMBL7248418 | 0.69 | — | — | |
| SCHEMBL1463490 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240173320-A1 | METHODS OF USING EHMT2 INHIBITORS IN IMMUNOTHERAPIES | Epizyme, Inc. | 2024-05-30 | — | — | US | disclosed |
| US-20210213014-A1 | METHODS OF USING EHMT2 INHIBITORS IN IMMUNOTHERAPIES | Epizyme, Inc. | 2021-07-15 | — | — | US | disclosed |
| WO-2018231176-A9 | COMBINATIONS OF DICLOFENAC AND H2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN AND INFLAMMATION | PISAK MEHMET NEVZAT (TR) | 2019-04-04 | — | — | WO | disclosed |
| WO-2018231175-A2 | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND H2 RECEPTOR ANTAGONIST COMBINATIONS FOR TREATMENT OF PAIN AND INFLAMMATION | IMUNEKS FARMA ILAÇ SANAYI VE TICARET ANONIM SIRKETI (TR) | 2018-12-20 | — | — | WO | disclosed |
| WO-2018231176-A2 | COMBINATIONS OF DICLOFENAC AND H2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN AND INFLAMMATION | PISAK MEHMET NEVZAT (TR) | 2018-12-20 | — | — | WO | disclosed |
| US-20150203812-A1 | Inhibitors of Voltage Gated Ion Channels | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2015-07-23 | — | — | US | disclosed |
| WO-2013054352-A1 | PHARMACEUTICAL COMPOSITIONS OF IBUPROFEN AND FAMOTIDINE | CADILA HEALTHCARE LIMITED (IN) | 2013-04-18 | — | — | WO | disclosed |
| EP-0367484-A1 | Carboxylic acid derivates | GLAXO GROUP LIMITED (GB) | 1990-05-09 | — | — | EP | disclosed |
| EP-0106080-B1 | HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THESE COMPOUNDS | LUDWIG HEUMANN & CO GMBH (DE) | 1987-01-28 | — | — | EP | disclosed |